drugset / Trial / NCT01316601
A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
Test safety and efficacy and of a novel IL-13 AB in the treatment of perianal fistulas * Trial with medicinal product
Timeline
- Start
- 2011-01
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QAX576 | Monoclonal antibody | — | — |